Trading Comps
Also written Trading Comps (market based multiples) · Trading comparables · Market based multiples
Relative valuation using multiples read off current market prices — principally the P/E ratio and the Price to Book Value ratio — as the workbook defines the term.
In plain language
Trading comps value a company by asking what the market is paying, right now, for a share of a similar company.
The workbook's definition is specific: trading comps are the market based multiples, and the two it names are the P/E ratio and the Price to Book Value ratio. Both put a market price in the numerator, which is what makes them "trading" multiples: they are read off a live screen.
That also sets their limit. A company with no market price has no trading comp of its own — which is the position of every investee company a Category I or II AIF holds.
How it works
The P/E ratio is the most widely used market-related multiple in valuation, and the workbook describes it as a useful metric for gauging a company's value as a multiple of its current earning capacity. It can also be used to compare unlisted companies in the alternative space with their listed peers, to know the range at which they are being valued.
The P/BV ratio compares market value to networth. In listed companies, a market value of 4 to 5 times book value is considered a healthy valuation; in unlisted companies, a DCF value can be cross-checked against the book value multiple.
For unlisted companies the workbook says trading comps are quite unsuitable, and at best the current market multiples of listed surrogates may be used. That difficulty is exactly why relative valuation developed firm value multiples — EV-based measures that determine value without reference to a market price at all.
One structural warning applies to every multiple in the chapter: relative valuation determines the enterprise value, so outstanding debt has to come off to reach equity value.
The formula
P/E ratio = Market price per share ÷ Earnings per share
P/BV ratio = Market value ÷ Networth
And running it backwards, as Illustration 11.8 does:
Market price = P/E × EPS
A worked example
Illustration 11.8 first. Alpha Ltd: after-tax profit Rs 100 lakh, paid-up capital Rs 200 lakh in 20 lakh shares of Rs 10, trading at a P/E of 32.
EPS = 1,00,00,000 ÷ 20,00,000 = Rs 5
Market price = 32 × 5 = Rs 160 per share
Now a Category II AIF valuing an unlisted logistics company with PAT of Rs 96 crore on 12 crore shares — EPS Rs 8. Its three closest listed peers trade at P/E multiples of 28, 34 and 31:
| Step | Working | Value per share |
|---|---|---|
| Median listed P/E | 31 × 8 | Rs 248 |
| Less: illiquidity discount at 30% | Rs 173.60 | |
| Implied equity value | 12 crore × 173.60 | Rs 2,083 crore |
The Rs 74.40 a share knocked off — Rs 893 crore in total — is the entire difference between a quoted share and one that cannot be sold on a Tuesday morning. If the company files for an IPO and the manager believes the exit is imminent, that discount narrows and the carrying value rises without the business changing at all.
Illustration 11.7 shows where the other trading comp gives out. A start-up funds itself with equity at a premium, books the premium to reserves, then burns through it. Accumulated losses wipe out the reserves and can erode the nominal value of the subscribed capital, so book value goes negative — and P/BV cannot be used at all.
Why NISM asks about it
Chapter 11 (Valuation), section 11.7 and sub-sections 11.7.2 and 11.7.3, with Illustrations 11.7 and 11.8. Expect a P/E computation of the Illustration 11.8 shape, and a conceptual question on why trading comps are unsuitable for unlisted companies — no market price validation, so you are reduced to listed surrogates.
Common exam traps
- Learn the workbook's own mapping. It calls the P/E and P/BV multiples "Trading Comps" and the EV/EBITDA and EV/Sales multiples "Deal Comps". Market practice outside the workbook often uses "trading comps" for any multiple derived from listed peers, EV multiples included. Answer the exam on the workbook's mapping.
- P/BV breaks on negative book value, which is normal for a loss-making start-up. Illustration 11.7 exists to make this point.
- Trading comps need a market price. For an unlisted company you are borrowing a listed surrogate's multiple, and the workbook calls that at best a second choice.
- Apply an illiquidity discount when carrying a listed multiple across to unlisted stock — reduced if an exit is imminent, per the IPEV discussion in the same chapter.
- The "4 to 5 times book value is healthy" observation is about listed companies. Do not apply it as a rule to an unlisted investee.
- P/E pairs equity price with equity earnings. Do not mix it with enterprise value.
Check yourself
1.Which of the following is NOT among the stated disadvantages of relative valuation?
- a)It does not take into account future capital expenditure and incremental working capital requirements
- b)It is suitable only when companies have reached maturity and are quite stable in their future outlook
- c)The selection of multiples is subjective
- d)It cannot be applied to companies whose shares are listed on a stock exchange
Show the answer
Answer: (d) It cannot be applied to companies whose shares are listed on a stock exchange
Relative valuation is most applicable to listed companies - trading comps such as the P/E and P/BV ratios are drawn from quoted prices. The difficulty runs the other way: for unlisted companies, trading comps are quite unsuitable, and at best current market multiples applicable to listed surrogates may be used. That is why firm value multiples were developed, to determine value without reference to the market price.
The four genuine disadvantages are:
(a) it does not take into account future capital expenditure and incremental working capital requirements, which could significantly affect value (b) it is suitable only when companies have reached maturity and are quite stable in their future outlook (c) the selection of multiples is subjective (d) multiples are driven by external factors which could alter a company's valuation without there being any fundamental shift in its intrinsic value between two given points of time
Point (d) catches most investors out - a sector-wide de-rating drags a perfectly healthy company down with it.
Where this is taught
Free preparation for NISM Series XIX-DRelated terms
- Enterprise ValueWhat it would cost to buy the whole business — market capitalisation plus debt, less cash — as opposed to market capitalisation, which buys only the equity.
- Price to Book ValueShare price divided by book value per share — how many times the accounting net worth of a company the market is willing to pay.
- Cost approachValuing a business from its assets less its liabilities — by book value, by what it would cost to replace, or by what it would fetch if broken up and sold.
- Deal CompsRelative valuation using earnings based multiples — chiefly EV/EBITDA and EV/Sales — which the workbook also calls Transaction Comparables.
- Market approachValuing a business from what the market pays for comparable businesses, using earnings and market multiples rather than the company's own projected cash flows.